Sino Biopharmaceutical | 1177 - Betriebsaufwand





Betriebsaufwand Veränderung Datum
Akebia Therapeutics USD 63.08M 8.26M 2025-12
Alaunos Therapeutics USD 1.01M 175K 2026-03
Avita Medical AUD 28.02M 1.55M 2025-12
Cspc Pharmaceutical CNY 5.91B 512.77M 2025-12
Dianthus Therapeutics USD 47M 22.83M 2026-03
Ionis Pharmaceuticals USD 370.24M 6.24M 2026-06
IQVIA Holdings USD 1.77B 4.45B 2026-06
Jiangsu Hengrui CNY 5.52B 604.29M 2026-03
Moderna USD 960M 817M 2026-06
Organon & Co USD 903M 387M 2026-03
Revvity USD 603.55M 24.8M 2026-06
Sino Biopharmaceutical CNY 12.39B 1.26B 2025-06
Tectonic Therapeutic USD 27.3M 5.78M 2026-03
Viatris USD 3.68B 145.9M 2026-06
Xeris Pharmaceuticals USD 75.21M 6.18M 2026-03